Accurate Rx Pharmacy (Accurate Rx Pharmacy Consulting, LLC), Columbia, MO
Is Accurate Rx Pharmacy (Accurate Rx Pharmacy Consulting, LLC) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Accurate Rx Pharmacy (Accurate Rx Pharmacy Consulting, LLC) hold a Missouri pharmacy license?
State board of pharmacy records for Missouri are not checked: the Division of Professional Registration’s license downloads sit on a script-driven portal, and its robots.txt file disallows the board’s pharmacy pages. The Colorado State Board of Pharmacy also lists nonresident license OSP 6834 for Accurate Rx Pharmacy, Columbia, MO, status Expired, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054016755 for ACCURATE RX PHARMACY CONSULTING LLC (dba ACCURATE RX PHARMACY), COLUMBIA, MO, status CHANGE OF OWNERSHIP, license 054020522 for ACCURATE RX PHARMACY CONSULTING, LLC, COLUMBIA, MO, status CHANGE OF OWNERSHIP and license 054021514 for ACCURATE RX PHARMACY CONSULTING LLC, COLUMBIA, MO, status NOT RENEWED, as of Nov 13, 2026.
Has Accurate Rx Pharmacy (Accurate Rx Pharmacy Consulting, LLC) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Sep 2, 2020), 1 state referral letter (Jun 16, 2022) and 1 FMD-145 letter (Jun 16, 2022) for Accurate Rx Pharmacy (Accurate Rx Pharmacy Consulting, LLC). State board of pharmacy records for Missouri are not checked: the Division of Professional Registration’s license downloads sit on a script-driven portal, and its robots.txt file disallows the board’s pharmacy pages. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- Accurate Rx Pharmacy Consulting, LLC; Accurate Rx Pharmacy
- Location
- Columbia, MO
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Jun 16, 2022
- FDA Data Dashboard inspections
- 3 inspections: 1 OAI, 2 VAI; 3 published Form 483s
- Form 483 text on this page
- 2 Form 483s, 4 observations
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as Accurate Rx Pharmacy Consulting, LLC (dba Accurate Rx Pharmacy), a 503A facility, with 4 dated actions.
| Document | |||
|---|---|---|---|
| Jun 16, 2022 | FMD-145 letter | FMD-145 Letter Issued 06/16/2022 | Not linked by FDA |
| Jun 16, 2022 | State referral letter | Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022 | fda.gov |
| Jul 15, 2021 | Form 483 | 483 Issued 07/15/2021 | fda.gov |
| Sep 2, 2020 | Warning letter | Warning Letter (09/02/2020) | fda.gov |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists Accurate RX Pharmacy Consulting LLC, Columbia, MO (FEI number 3013446837), matched to this page by exact name, city and state. It lists 3 inspections: 1 OAI, 2 VAI at that site, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile.
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jul 15, 2021 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3013446837 | 1147006 |
| Sep 19, 2018 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3013446837 | 1067033 |
| Aug 14, 2017 | Voluntary Action Indicated (VAI) | Drug Quality Assurance (Drugs) | 3013446837 | 1022616 |
Form 483s FDA has published for this site
- Jul 15, 2021: Form 483 to Accurate RX Pharmacy Consulting LLC, published Oct 20, 2021. fda.gov
- Sep 19, 2018: Form 483 to Accurate RX Pharmacy Consulting LLC, published May 4, 2020. fda.gov
- Sep 21, 2017: Form 483 to Accurate RX Pharmacy Consulting LLC, published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483s for this site have 4 numbered observations in all, across 2 inspections ending Sep 21, 2017 to Sep 19, 2018. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Sep 10, 2018 to Sep 19, 2018: 3 observations
- Firm on the cover
- Accurate RX Pharmacy Consulting LLC, 103 Corporate Lake Dr Ste B, Columbia, MO 65203-7290
- FEI number
- 3013446837
- Establishment type on the cover
- Producer of Sterile Drugs
- FDA district office on the cover
- 300 River Place, Suite 5900 Detroit, MI 48207
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
The ISO 5 classified aseptic processing area was located within a non-classified room (segregated production area).
Specifically,
A. Your ISO 5 <Redacted B4>, which is utilized to produce human sterile drug products that are admimstered with Beyond Use Dates greater than 12 hours, is in a non-classified segregated room. For example, the following prescriptions for human sterile drug products were produced in the ISO 5 <Redacted B4> between 6/10/2018 - 9/10/2018:
Vancomycin 225 mg/NS 45 mL for Rx <Redacted B4> on 8/09/2018. BUD = 14 days refrigerated.
Gannnagard SID Less IgA 30 g/600 mL for Rx <Redacted B4> on 8/14/2018. BUD= 3 days refrigerated after reconstitution.
B. The ISO 5 <Redacted B4> , is <Redacted B4> in the open position during cleaning and <Redacted B4> certification operations, exposing both ISO 5 chambers ( ante & main) to unclassified air from within the non-classified room. ...
Observation 2
Disinfecting agents and cleaning wipes used in the ISO 5 classified aseptic processing areas were not sterile.
Specifically,
You utilize the following non-sterile cleaning products to clean the ISO 5 <Redacted B4>, which is utilized to produce human sterile drug products:
•(<Redacted B4> spray solution (germicidal)
•<Redacted B4> cleaning wipes (lint-free)
On 9/11/2018, after production of Gammagard SID Less IgA 30 g/600 mL for Rx <Redacted B4>, you used the aforementioned non-sterile cleaning products during post-cleaning. If the ISO 5 <Redacted B4> . These non-sterile cleaning products are also used to clean the ISO 5 <Redacted B4> at the beginning of each work day, as evidenced in your cleaning logs and referenced in your Policy SOP, PO-10 Hood Cleaning Policy and Log.
Observation 3
Sporicidal agents were not used in your facility's cleanrooms and/or ISO 5 classified aseptic processing area.
Specifically,
The germicidal agent, <Redacted B4> used when cleaning the ISO 5 <Redacted B4> before and after aseptic processing of human sterile drug products, is not considered to be a sporicidal agent.
Inspection dated Sep 21, 2017 by FDA (dates on the form not read): 1 observation
- Firm on the cover
- 103 Corporate Lake Drive, Suite B Accurate Rx Pharmacy Consulting, LLC dba Accurate Rx Pharm, Producer of sterile drugs Columbia, MO 65203-7290
- FEI number
- 3013446837
- FDA district office on the cover
- 7/31/2017, 8/1/2017, 8/8/2017, and 8/14/2017. FDA Kansas District Office 8050 Marshall Drive, Suite 205 Lenexa, KS 66214
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
This 483 is a scanned image. The text below is the PDF’s own text layer, which can misread characters; the PDF is the record.
Observation 1
:
Your ISO 5 classified workstation where sterile product are prepared is located within a non-classified room.
Specifically,
A. Your <R edacted B 4> "compounding aseptic <Redacted B4>" is not located in a controlled environme nt/room in order to prevent the risk of contamination. On 7/31/2017, during the production of saline water bags,
the <Redacted B4> was observed to be equippe d with < Redacted B4> and is the refore not completely enclosed to the environment. Ad ditionall y, <Redacted B4> is not used every day and it is
turned off when it i s not in use. <Redacted B4> for cleaning and disinfection.
B.The ISO 5 classified area is in close proximity to the sink and no barriers exists between the sink and the " compounding aseptic <Redacted B4>" to prevent risk of contamination.
Linked 483s whose text is not shown
- Jul 15, 2021: FDA document 152619: its numbered observations could not be read reliably from the PDF text.
State board of pharmacy records
State board of pharmacy records for Missouri are not checked: the Division of Professional Registration’s license downloads sit on a script-driven portal, and its robots.txt file disallows the board’s pharmacy pages.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| OSP 6834 | OSP | Accurate Rx Pharmacy | Columbia, MO | Expired |
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054016755 | LICENSED PHARMACY | ACCURATE RX PHARMACY CONSULTING LLC (dba ACCURATE RX PHARMACY) | COLUMBIA, MO | CHANGE OF OWNERSHIP |
| 054020522 | LICENSED PHARMACY | ACCURATE RX PHARMACY CONSULTING, LLC | COLUMBIA, MO | CHANGE OF OWNERSHIP |
| 054021514 | LICENSED PHARMACY | ACCURATE RX PHARMACY CONSULTING LLC | COLUMBIA, MO | NOT RENEWED |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
Records last pulled Nov 15, 2026. Every entry links to the original public record.